AZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2 | MicrobiomeTrials← Back to trialsNCT06219941
AZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2023-12-13Est. Completion: 2026-11-17
Enrollment target: 226 participants Locations- Research Site, Orange, California, United States
- Research Site, Palo Alto, California, United States
- Research Site, Santa Rosa, California, United States
- Research Site, Louisville, Kentucky, United States
- Research Site, Commack, New York, United States
- Research Site, Providence, Rhode Island, United States
- Research Site, Houston, Texas, United States
- Research Site, Melbourne, Australia
- Research Site, Murdoch, Australia
- Research Site, Randwick, Australia
- Research Site, Kingston, Ontario, Canada
- Research Site, Toronto, Ontario, Canada
- Research Site, Montreal, Quebec, Canada
- Research Site, Sherbrooke, Quebec, Canada
- Research Site, Changsha, China
- Research Site, Chengdu, China
- Research Site, Tbilisi, Georgia
- Research Site, Chūōku, Japan
- Research Site, Kashiwa, Japan
- Research Site, Kitaadachi-gun, Japan
Other microbiome trials you might be interested in
Esophageal CancerGastric (Cardia, Body) Cancer
The overall goal of this project is to understand the role of genetics in the etiology and prevention of upper gastroint…
Taiyuan, ChinaCompleted Mar 18, 2020
Advanced Gastrointestinal Cancer
This clinical trial is designed to study an investigational cell therapy called cCTL-GL01 in patients with advanced gast…
Multiple LocationsEst. completion Aug 1, 2028
Research Site, Kōtoku, JapanResearch Site, Nagoya, JapanResearch Site, Osakasayama-shi, JapanResearch Site, George Town, MalaysiaResearch Site, Johor Bahru, MalaysiaResearch Site, Kuala Lumpur, MalaysiaResearch Site, Kuala Selangor, MalaysiaResearch Site, Kuching, MalaysiaResearch Site, Chisinau, MoldovaResearch Site, Krakow, PolandResearch Site, Warsaw, PolandResearch Site, Bukit Merah, SingaporeResearch Site, Singapore, SingaporeResearch Site, Singapore, SingaporeResearch Site, Singapore, SingaporeResearch Site, Gyeonggi-do, South KoreaResearch Site, Seoul, South KoreaResearch Site, Seoul, South KoreaResearch Site, Seoul, South KoreaResearch Site, Seoul, South KoreaResearch Site, Barcelona, SpainResearch Site, Madrid, SpainResearch Site, Madrid, SpainResearch Site, Kaohsiung City, TaiwanResearch Site, Taichung, TaiwanResearch Site, Tainan, TaiwanResearch Site, Taipei, TaiwanResearch Site, Taoyuan, TaiwanResearch Site, Glasgow, United KingdomResearch Site, Leeds, United KingdomResearch Site, London, United KingdomResearch Site, Oxford, United KingdomPhase 1
Recruiting
Metastatic Hepatocellular CarcinomaLocal Advanced Hepatocellular CarcinomaAlpha-fetoprotein (AFP)-Producing Gastric CancerExtragonadal Yolk Sac TumorsGlypican-3 (GPC3)-Positive Squamous Non-small Cell Lung Cancer
This is a first-in-human (FIH) clinical study designed to evaluate the safety, tolerability, pharmacokinetics (PK), phar…
Goodyear, United StatesEst. completion May 30, 2028